ANTICOAGULANTS
Anticoagulant medicines work
by interrupting part of the
process involved in the
formation of blood clots.
Blood clots are...
Deep Vein
Trombosis
Pulmonary
Embolism
Risk of a
stroke
Atrial
Fibrillation
Risk of
developing
Blood Clots
After
Surgery
W...
YEARLY EXPENSES
In 2008, 6,2 billion US Dollars
were spent on anticoagulants
In 2014, 9,1 billion US Dollars
were spent on...
Warfarin has shown to
reduce the risk of AF-
related strokes by 64%
as opposed to 19% by
Antiplatelets such as
Aspirin
Due to serious side-effects,
medicine optimisation is
necessary
The NOACs: Apixaban,
Dabigatronetexilate & Rivaroxaban
are...
Preventive stroke care will save
governments enormous amounts of
money
Continuous optimisation
safer medicines
Talentum BioTech offers
customized molecular simulation and
bioactive compound discovery services
to biopharma companies &...
Upcoming SlideShare
Loading in …5
×

Anticoagulants: research in development

219 views

Published on

Talentum BioTech supports novel anticoagulants research.

There are many sorts of Anticoagulants, but continuous optimisation is needed. Talentum BioTech supports biopharma research by means of innovative biotech/bioinformatics services. Anticoagulants is solely one type of the numerous expertises that the company has.

Published in: Health & Medicine
  • Be the first to comment

Anticoagulants: research in development

  1. 1. ANTICOAGULANTS
  2. 2. Anticoagulant medicines work by interrupting part of the process involved in the formation of blood clots. Blood clots are less likely to form where they are not needed, but can still form when they are needed
  3. 3. Deep Vein Trombosis Pulmonary Embolism Risk of a stroke Atrial Fibrillation Risk of developing Blood Clots After Surgery What are anticoagulants used for?
  4. 4. YEARLY EXPENSES In 2008, 6,2 billion US Dollars were spent on anticoagulants In 2014, 9,1 billion US Dollars were spent on anticoagulants LMWH DTI Heparin Factor Xa inhibitors Warfarin Other LMWH DTI Heparin Factor Xa inhibitors Warfarin OtherSource: http://www.nature.com/nrd/journa l/v8/n5/fig_tab/nrd2851_ft.html
  5. 5. Warfarin has shown to reduce the risk of AF- related strokes by 64% as opposed to 19% by Antiplatelets such as Aspirin
  6. 6. Due to serious side-effects, medicine optimisation is necessary The NOACs: Apixaban, Dabigatronetexilate & Rivaroxaban are the first major innovation in the prevention of non valvular Atrial Fibration stroke in 50 years http://www.abpi.org.uk/our-work/library/medical-disease/Documents/ABPI%20SAFI%20report.pdf
  7. 7. Preventive stroke care will save governments enormous amounts of money Continuous optimisation safer medicines
  8. 8. Talentum BioTech offers customized molecular simulation and bioactive compound discovery services to biopharma companies & academic research groups Talentum BioTech has experience in the field of Anticoagulants Click on logo to directly visit our website (http://www.talentum-biotech.com/en/)

×